Skip to content
Lower risk Drug recall · FDA · Published April 21, 2026

Alcon GenTeal Tears Eye Gel Recall: Lack of Sterility Assurance

Alcon recalls sterile GenTeal Tears eye gel due to potential lack of sterility. Products distributed by Alcon Laboratories with specific lot numbers and expiration dates are affected. Consumers should check their product details and contact Alcon for guidance.

🇺🇸 FDA recall #D-0492-2026DrugAlcon ›
Take action

Contact the company

Recalling firmAlcon Research LLC6201 South Fwy · Fort Worth, TX 76134-2099
✎ GovInfoNow plain-language explainer

What happened, in plain English

Alcon is recalling sterile eye gel products called GenTeal Tears because of concerns about possible lack of sterility. This could lead to infections if the product is not properly sterile. The recall affects specific lot numbers and expiration dates. Read more at govinfonow.com/recall/31341-alcon-genteal-tears-eye-gel-recall-lack-of-sterility-assurance.

Source Summary by GovInfoNow · govinfonow.com/recall/31341-alcon-genteal-tears-eye-gel-recall-lack-of-sterility-assurance · Updated August 17, 2026 · FDA enforcement record: FDA #D-0492-2026

Cite this page

“Alcon GenTeal Tears Eye Gel Recall: Lack of Sterility Assurance.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31341-alcon-genteal-tears-eye-gel-recall-lack-of-sterility-assurance. Based on FDA recall #D-0492-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0492-2026%22&limit=1).

Why it’s dangerous

The product may not be sterile due to FDA inspection observations that could impact quality. If the eye gel is not sterile, it could cause eye infections or irritation when used.

Who’s affected

People who own or use GenTeal Tears eye gel with the specific lot numbers and expiration dates listed in the recall notice. Those with sensitive eyes or compromised immune systems may be at slightly higher risk.

How to tell if you have this one

Check the product label for the lot numbers: 9T20, 9T50, 9T59, 1U30, 1U48, 7V61, 1W47, 1W49, 1X14. Also look for the expiration dates: 4/30/2026, 8/31/2026, 12/31/2026, or 3/31/2027.

  • Brand
    Alcon
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Nationwide within the United States
Recall numberProduct, codes & lotsQuantityNDC
D-0491-2026Systane, Lubricant Eye Gel, Night Gel, Sterile, 10g (0.35 oz), Processed in France for: Alcon Laboratiroes, Inc., Fort Worth, TX 76134, USA, NDC 0065-0474-01; Lot#: 9T21, Exp Date: 4/30/2026; Lot# 1U63, 2U47, Exp Date: 5/31/2026; Lot# 6V00, 6V12, 8V54, Exp Date: 1/31/2027; Lot# 9V55, 8V58, 9V39, 9V97, Exp Date: 2/28/2027; Lot# 1W39, 1W40, Exp Date: 3/31/2027; Lot# 1X76, Exp Date: 4/30/2027.—0065-0474-01, 0065-0474-02
D-0492-2026GenTeal Tears, Lubricant Eye Gel, Sterile, 10g (0.34 Fl oz), Distributed by: Alcon Laboratories, Inc., Fort Worth, Texas 76134, USA, NDC: 0065-8064-01.; Lot #: 9T20, 9T50, 9T59, 1U30, 1U48, Exp Date: 4/30/2026; 4V15, Exp Date: 8/31/2026; 7V61, Exp Date: 12/31/2026; 1W47, 1W49, 1X14, Exp Date: 3/31/2027.—0065-8064-01
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the lot numbers and expiration dates on the product label to confirm if it is affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 15 days after the firm started it.

1. Firm started the recall: Apr 21, 202612. FDA classified it Class II: Apr 24, 202623. Published in FDA’s Enforcement Report: May 6, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0492-2026 (April 21, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0492-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA